̽»¨¾«Ñ¡

NK cells in the development of adaptive immune responses – Benedict Chambers team

The main focus of our research is to investigate the role of natural killer (NK) cells in the development of adaptive immune responses. The research focuses along two lines. (1) The interaction between dendritic cells (DC) and NK cells. (2) How NK cells can affect T and B cell mediated responses by direct physical interaction.

Our research

Our current interests:

(i) examining adhesion molecules in the development of immune responses. In particular, we are examining these on innate immune cells and how they can promote adaptive immune responses. We find that these molecules affect checkpoint molecules such as PD-1, LAG3 and TIM3 which has implications in anti-tumor responses by immune cells. Expression of these adhesion molecules on immune cells could also identify which patients might benefit from immunotherapy using anti-checkpoint antibodies.

(ii) examining the role of voltage dependent calcium channels (VDCC) on immune responses. We have previously found that immune can make GABA which could dampen immune responses. GABA can affect immune cell polarization through VDCCs. We have found that VDCCs can affect NK cell function and we are currently examining how this is achieved.

Open positions

We always want to get in touch with talented potential co-workers. If you are interested in doing research within our group, as a degree project or as a researcher, please contact the group leader: benedict.chambers@ki.se

Publications

Selected publications

  • Article: FRONTIERS IN IMMUNOLOGY. 2018;9:505
    Vashist N; Trittel S; Ebensen T; Chambers BJ; Guzman CA; Riese P
  • Article: PLOS PATHOGENS. 2017;13(12):e1006739
    Kanatani S; Fuks JM; Olafsson EB; Westermark L; Chambers B; Varas-Godoy M; Uhlen P; Barragan A
  • Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;75(1):54-60
    Dominguez-Villar M; Garcia-Cozar FJ; Chambers BJ
  • Article: INFECTION AND IMMUNITY. 2011;79(8):3046-3052
    Dellacasa-Lindberg I; Fuks JM; Arrighi RBG; Lambert H; Wallin RPA; Chambers BJ; Barragan A
  • Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2010;40(8):2155-2164
    Persson CM; Chambers BJ
  • Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2009;86(1):91-101
    Seth S; Georgoudaki A-M; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G
  • Article: INFECTION AND IMMUNITY. 2009;77(3):970-976
    Persson CM; Lambert H; Vutova PP; Dellacasa-Lindberg I; Nederby J; Yagita H; Ljunggren H-G; Grandien A; Barragan A; Chambers BJ
  • Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2008;83(1):56-63
    Wagner CS; Walther-Jallow L; Buentke E; Ljunggren H-G; Achour A; Chambers BJ
  • Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;67(1):30-36
    Persson CM; Assarsson E; Vahlne G; Brodin P; Chambers BJ
  • Article: CANCER RESEARCH. 2007;67(18):8450-8455
    Chambers B; Grufman P; Fredriksson V; Andersson K; Roseboom M; Laban S; Camps M; Wolpert EZ; Wiertz EJHJ; Offringa R; Ljunggren H-G; van Hall T
  • Article: JOURNAL OF IMMUNOLOGY. 2004;173(1):174-180
    Assarsson E; Kambayashi T; Schatzle JD; Cramer SO; von Bonin A; Jensen PE; Ljunggren HG; Chambers BJ
  • Article: JOURNAL OF IMMUNOLOGY. 2004;172(1):123-129
    Hayakawa Y; Screpanti V; Yagita H; Grandien A; Ljunggren HG; Smyth MJ; Chambers BJ
Keywords:
Adaptive Immunity Immunology in the Medical Area Killer Cells, Natural Microbiology in the Medical Area
Content reviewer:
01-04-2025